Pier 88 Investment Partners LLC Ultragenyx Pharmaceutical Inc. Transaction History
Pier 88 Investment Partners LLC
- $75.6 Million
- Q4 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 14,090 shares of RARE stock, worth $554,300. This represents 0.78% of its overall portfolio holdings.
Number of Shares
14,090
Previous 22,540
37.49%
Holding current value
$554,300
Previous $1.25 Million
52.72%
% of portfolio
0.78%
Previous 1.65%
Shares
22 transactions
Others Institutions Holding RARE
# of Institutions
345Shares Held
86.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$395 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$220 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$169 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$107 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$98.8 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.76B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...